慢阻肺患者影像学检出冠心病的患病率与临床相关性:横断面观察研究
该研究通过CT冠状动脉造影前瞻性评估50例慢阻肺患者及年龄性别匹配对照的冠心病负担,发现慢阻肺患者冠心病患病率高达88%,且与症状和传统风险评分相关性差。胸部CT衍生的冠状动脉钙化评分筛查冠心病和梗阻性冠心病的曲线下面积分别为0.98和0.89。
要点
- 慢阻肺患者CT冠脉造影检出冠心病达88%,梗阻性和严重梗阻性病变均高于对照。
- 75%的冠心病患者无胸痛或既往缺血性心脏病史,症状与冠脉病变相关性差。
- 胸部CT衍生的冠脉钙化评分对冠心病筛查曲线下面积达0.98,可能改善检出。
核心结论
- CT冠脉造影检出的冠心病在慢阻肺患者中常见,但与症状及传统风险评分相关性差。
- 标准胸部CT的影像学筛查可能改善该人群的冠心病检出和结局。
研究设计与样本
- 前瞻性横断面观察研究,纳入50例慢阻肺患者并与年龄性别匹配对照比较,采用CT冠状动脉造影评估冠心病。
主要发现
- 慢阻肺患者冠心病患病率88%,其中42%为梗阻性(任一血管狭窄≥50%),28%为严重梗阻性(狭窄≥70%)。
- 慢阻肺患者梗阻性冠心病OR为3.1(95%CI 1.1-8.9,P=0.037),严重梗阻性冠心病OR为10.1(95%CI 1.9-52.7,P=0.006)。
- 慢阻肺合并冠心病者功能受损更重但呼吸困难评分无增加,75%无胸痛或既往缺血性心脏病史。
- 冠心病在全身炎症指标升高、支气管壁增厚和痰细菌生长者中更广泛,与急性加重频率无关。
- 胸部CT衍生冠脉钙化评分筛查冠心病AUC为0.98(95%CI 0.95-1.00),筛查梗阻性冠心病AUC为0.89(95%CI 0.79-1.00)。
关键数值与推荐
- 梗阻性冠心病定义为任一血管狭窄≥50%,严重梗阻性定义为狭窄≥70%。
- 冠心病与全身炎症(纤维蛋白原、C反应蛋白、白细胞和中性粒细胞计数)、支气管壁增厚及痰细菌生长相关。
临床怎么用
- 对慢阻肺患者应警惕无症状冠心病,不应仅凭症状和传统风险评分排除。
- 可考虑利用标准胸部CT衍生的冠脉钙化评分辅助冠心病筛查。
局限性
- 样本量较小(50例慢阻肺患者),为单中心横断面观察研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Unrecognized coronary artery disease (CAD) may contribute to adverse outcomes in chronic obstructive pulmonary disease (COPD). Improved identification of at-risk groups could inform better preventive care. Objectives: We aimed to evaluate the burden and relationships of radiologically detectable CAD in COPD, establish the frequency of occult disease, and examine potential cardiovascular screening methods. Methods: Using computed tomography (CT) coronary angiography, we prospectively evaluated CAD in 50 patients with COPD compared with age- and sex-matched controls. In those with COPD, the relationship of CAD to cardiac symptoms (chest pain, dyspnea), functional capacity (6-minute-walk distance), exacerbations, and inflammation was assessed. The performance of screening tests (cardiovascular risk scores, biomarkers, and thoracic CT-derived coronary artery calcium score) were evaluated using receiver operating characteristic curves. Measurements and Main Results: CAD was present in 88% of patients with COPD (42% had obstructive [⩾50% stenosis of any vessel] and 28% severely obstructive [⩾70%] disease). Rates of obstructive (OR, 3.1; 95% CI, 1.1-8.9; P = 0.037) and severely obstructive CAD (OR, 10.1; 95% CI, 1.9-52.7; P = 0.006) were higher in those with COPD than in controls. In the COPD group, those with CAD had greater functional impairments but not greater dyspnea scores, and 75% reported no chest pain or prior ischemic heart disease. CAD was more extensive in those with increased systemic inflammation (fibrinogen, C-reactive protein, and leukocyte and neutrophil counts), bronchial wall thickening, and sputum bacterial growth but bore no relation to exacerbation frequency. The thoracic CT-derived coronary artery calcium score was an effective screening tool, with areas under the curve of 0.98 (95% CI, 0.95-1.00) for CAD and 0.89 (95% CI, 0.79-1.00) for obstructive CAD. Conclusions: CT coronary angiography-detected CAD is common in patients with COPD but correlates poorly with symptoms and conventional risk scores. Radiological screening with standard (non ECG-gated) CT of the thorax might improve detection and outcome in this patient group.
引用
- MacLeod MA, Knott KD, Allinson JP, et al. Prevalence and Clinical Correlates of Radiologically Detected Coronary Artery Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Observational Study. Am J Respir Crit Care Med. 2025. PMID: 39680915. doi:10.1164/rccm.202404-0838OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。